Large-scale testing (Phase 3)Study completedNCT01782937What this trial is testingAn Open-label, Non-controlled Study of KHK4827 in Subjects With PsoriasisWho this might be right forPsoriasis Kyowa Kirin Co., Ltd. 30
Post-approval studies (Phase 4)Ended earlyNCT05710185What this trial is testingDeucravacitinib for the Treatment of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Brigham and Women's Hospital 3
Large-scale testing (Phase 3)Study completedNCT04451720What this trial is testingStudy of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) AbbVie 119
Large-scale testing (Phase 3)Study completedNCT05174065What this trial is testingPhase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)Who this might be right forPalmoplantar Pustulosis Amgen 176
Post-approval studies (Phase 4)Study completedNCT04183881What this trial is testingClinical Study of BrodalumabWho this might be right forPsoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more Kyowa Kirin Co., Ltd. 138
Not applicableUnknownNCT01952275What this trial is testingObservational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesWho this might be right forOther Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more University of Zurich 600
Large-scale testing (Phase 3)Study completedNCT03022045What this trial is testingAssess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic PsoriasisWho this might be right forPsoriasis AbbVie 18
Not applicableStudy completedNCT05670821What this trial is testingPMS of Spesolimab I.V. in GPP Patients With Acute SymptomsWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03886246What this trial is testingEffisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous StudyWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 131
Large-scale testing (Phase 3)Active Not RecruitingNCT06323356What this trial is testingTAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Takeda 18
Large-scale testing (Phase 3)Study completedNCT05239039What this trial is testingAn Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 39
Not applicableStudy completedNCT07428915What this trial is testingEvaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsWho this might be right forPustular Psoriasis (PP)Generalized Pustular Psoriasis (GPP)Eczema Atopic Dermatitis+11 more AI Labs Group S.L 15
Large-scale testing (Phase 3)Study completedNCT04061252What this trial is testingKHK4827 in Subjects With Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis Kyowa Kirin Co., Ltd. 126
Not applicableLooking for participantsNCT07270003What this trial is testingA Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) Xijing Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04399837What this trial is testingTest Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Boehringer Ingelheim 123
Large-scale testing (Phase 3)Looking for participantsNCT06477536What this trial is testingLong-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular PsoriasisWho this might be right forGeneralized Pustular Psoriasis Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Not applicableNot Yet RecruitingNCT07448428What this trial is testingGeneralized Pustular Psoriasis Registry in Costa RicaWho this might be right forGeneralized Pustular PsoriasisGeneralized Pustular Psoriasis (GPP) Caja Costarricense de Seguro Social 50
Early research (Phase 1)Study completedNCT05512598What this trial is testingHB0034 in Patients With Generalized Pustular Psoriasis (GPP)Who this might be right forGeneralized Pustular Psoriasis Shanghai Huaota Biopharmaceutical Co., Ltd. 9
Post-approval studies (Phase 4)Study completedNCT03942042What this trial is testingIxekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic PsoriasisWho this might be right forGeneralized Pustular PsoriasisErythrodermic Psoriasis Eli Lilly and Company 12
Post-approval studies (Phase 4)Looking for participantsNCT07503652What this trial is testingClinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis (PPP) First Hospital of China Medical University 10